Princeton10 Launches

To address leaner advertising budgets and make smaller healthcare brands more competitive, Marcos M. Sanchez – a veteran healthcare and pharmaceutical marketing and advertising executive – announced the launch of Princeton10, a marketing and advertising agency expressly focused on Rx brands seeking to drive HCP-patient demand.

Sanchez, who previously started, grew and sold a thriving multicultural agency is now partnering with smaller, “underdog brands” not well served by legacy healthcare agencies that routinely devote their best people to major launch and/or high-science brands to justify skyrocketing operational costs and overhead.

“Princeton10 is a David helping other Davids compete with the countless Goliaths in today’s pharmaceutical landscape,” explains Sanchez. “Typically, advertising agencies serving pharma are bloated by legacy assets amassed over decades, and the client-agency model is long overdue for an overhaul. At Princeton10, our clients work with senior, battle-tested thought leaders and specialists who don’t put accounts into the hands of junior staff who just bill long hours without delivering the improved business results clients expect. Princeton10 is bringing healthcare and pharmaceutical advertising to where it belongs…in 2018.”

The mission of Princeton10 is to offer premium partnership support for healthcare brands maximizing their budgets. The “10” in the agency’s name reflects its use of the top 10% of industry experts with proven success making smart choices for challenger Rx brands. A team of specialists – hand-picked by Sanchez for their proven expertise – are at a client’s disposal to deliver optimal customer experiences while remaining operationally lean and financially transparent.